Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy

Halle C.F. Moore, Joseph M. Unger, Kelly Anne Phillips, Frances Boyle, Erika Hitre, David Porter, Prudence A. Francis, Lori J. Goldstein, Henry L. Gomez, Carlos S. Vallejos, Ann H. Partridge, Shaker R. Dakhil, Agustin A. Garcia, Julie Gralow, Janine M. Lombard, John F. Forbe, Silvana Martino, William E. Barlow, Carol J. Fabian, Lori MinasianFrank L. Meyskens, Richard D. Gelber, Gabriel N. Hortobagyi, Kathy S. Albain

Research output: Comment/debate

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)392-393
Number of pages2
JournalObstetrical and Gynecological Survey
Volume70
Issue number6
DOIs
Publication statusPublished - jún. 17 2015

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Moore, H. C. F., Unger, J. M., Phillips, K. A., Boyle, F., Hitre, E., Porter, D., Francis, P. A., Goldstein, L. J., Gomez, H. L., Vallejos, C. S., Partridge, A. H., Dakhil, S. R., Garcia, A. A., Gralow, J., Lombard, J. M., Forbe, J. F., Martino, S., Barlow, W. E., Fabian, C. J., ... Albain, K. S. (2015). Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. Obstetrical and Gynecological Survey, 70(6), 392-393. https://doi.org/10.1097/01.ogx.0000467230.21869.a4